https://cenexel.com/esketamine-support-fda/2026-06-30T12:13:42+00:00https://cenexel.com/females-with-schizophrenia-for-clinical-trials/2026-06-30T11:54:45+00:00https://cenexel.com/anaheim-clinical-trials-a-cenexel-clinical-research-center-of-excellence-wins-audit-triple-crown/2026-06-30T12:11:13+00:00https://cenexel.com/cenexel-chief-scienti0c-advisor-todd-bertoch-md-to-lead-session-at-pain-therapeutics-summit-2019/2026-06-30T12:10:43+00:00https://cenexel.com/cenexel-clinical-research-acquires-research-centers-of-america/2026-06-30T12:09:07+00:00https://cenexel.com/cenexel-leads-industry-in-psychiatric-studies-at-atlanta-center-for-medical-research/2026-06-30T12:07:48+00:00https://cenexel.com/jbr-clinical-research-surgical-center-earns-prestigious-aaaasf-accreditation/2026-06-30T12:07:17+00:00https://cenexel.com/cenexels-research-centers-of-america-partners-with-top-leadership-to-fight-covid-19/2026-06-29T14:16:46+00:00https://cenexel.com/experts-at-cenexel-clinical-research-sites-tackle-covid-19-vaccine-testing/2026-06-30T12:06:07+00:00https://cenexel.com/cenexel-offers-expert-presentations-on-clinical-research-impacts-of-covid-19/2026-06-30T12:08:17+00:00https://cenexel.com/judith-montero-psyd-joins-cenexel-clinical-research-as-director-of-clinical-assessments/2026-06-30T12:06:55+00:00https://cenexel.com/cenexel-clinical-research-joins-decentralized-trials-research-alliance-dtra/2026-06-30T12:01:19+00:00https://cenexel.com/research-centers-of-america-expedite-broad-study-on-modernas-covid-19-vaccine/2026-06-30T12:00:55+00:00https://cenexel.com/cenexel-clinical-research-acquires-citrials/2026-06-29T14:27:12+00:00https://cenexel.com/cenexel-appoints-bethany-sensenig-as-chief-financial-officer/2026-06-29T10:49:39+00:00https://cenexel.com/cenexel-psychiatric-research-expert-presents-data-at-schizophrenia-international-research-society/2026-06-30T11:58:38+00:00https://cenexel.com/cenexel-acmr-offers-public-vaccinations-for-covid-19-in-atlanta-georgia/2026-06-30T11:58:15+00:00https://cenexel.com/heron-therapeutics-press-release/2026-06-30T11:57:11+00:00https://cenexel.com/first-in-human-study-of-oto-413/2026-06-30T12:00:25+00:00https://cenexel.com/heron-therapeutics-announces-publication-showing-reduction-of-pain-and-opioid-use-compared-to-bupivacaine-in-patients-65-and-older-with-zynrelef/2026-06-29T17:10:09+00:00https://cenexel.com/cenexel-clinical-research-acquires-forcare-clinical-research/2026-06-29T14:29:22+00:00https://cenexel.com/cenexel-clinical-research-acquires-advanced-memory-research-institute/2026-06-29T17:09:29+00:00https://cenexel.com/cali-biosciences-initiates-phase-2b-study-of-long-acting-ropivacaine-for-non-opioid-treatment-of-post-operative-pain/2026-06-29T17:09:46+00:00https://cenexel.com/analgesic-efficacy-and-safety-of-naproxen-sodium-versus-hydrocodone-acetaminophen-in-acute-postsurgical-dental-pain/2026-06-29T17:08:59+00:00https://cenexel.com/cenexel-clinical-research-acquires-california-neuroscience-research/2026-06-29T17:07:04+00:00https://cenexel.com/cenexel-clinical-research-acquires-rocky-mountain-movement-disorders-center/2026-06-29T17:06:43+00:00https://cenexel.com/healthy-feet-are-happy-feet-preventing-and-treating-bunions-and-ingrown-toenails/2026-06-29T17:05:32+00:00https://cenexel.com/cenexel-acquires-iresearch/2026-06-29T17:04:34+00:00https://cenexel.com/cenexel-acquires-apex/2026-06-29T17:04:08+00:00https://cenexel.com/human-abuse-potential-seo/2026-06-29T17:03:46+00:00https://cenexel.com/placebo-control-reminder-script/2026-06-30T12:24:09+00:00https://cenexel.com/cenexel-psychedelic-facilitators-are-undergoing-premier-certification-training/2026-06-29T17:01:54+00:00https://cenexel.com/validation-of-a-suite-of-erp-and-qeeg-biomarkers-in-a-pre-competitive-industry-led-study-in-subjects-with-schizophrenia-and-healthy-volunteers/2026-06-29T17:01:30+00:00https://cenexel.com/cenexel-creates-clinical-sciences-business-unit/2026-06-29T17:01:08+00:00https://cenexel.com/cenexel-cns-opens-centers-in-los-alamitos-california/2026-06-29T17:00:49+00:00https://cenexel.com/the-primer-on-the-autonomic-nervous-system-4th-edition/2026-06-29T17:00:13+00:00https://cenexel.com/emraclidine-a-novel-positive-allosteric-modulator-of-cholinergic-m4-receptors-for-the-treatment-of-schizophrenia-a-two-part-randomised-double-blind-placebo-controlled-phase-1b-trial/2026-06-29T16:59:49+00:00https://cenexel.com/efficacy-and-safety-of-olorinab-a-full-agonist-of-the-cannabinoid-receptor-2-for-the-treatment-of-abdominal-pain-in-patients-with-irritable-bowel-syndrome-results-from-a-phase-2b-randomized-placebo/2026-06-29T11:33:24+00:00https://cenexel.com/evaluation-of-mrna-1273-vaccine-in-children-6-months-to-5-years-of-age/2026-06-29T11:32:53+00:00https://cenexel.com/karuna-therapeutics-announces-positive-results-from-phase-3-emergent-3-trial-of-karxt-in-schizophrenia/2026-06-29T11:32:28+00:00https://cenexel.com/a-link-between-seizure-and-stuttering-disorders-a-case-report/2026-06-29T11:17:23+00:00https://cenexel.com/administrating-and-training-on-the-placebo-control-reminder-script-a-deeper-dive-into-the-tools-psychometric-properties/2026-06-29T11:17:06+00:00https://cenexel.com/the-placebo-control-reminder-script-and-supplementary-instrument-properties-evaluation-of-face-and-content-validity/2026-06-29T11:34:41+00:00https://cenexel.com/further-exploration-of-the-placebo-control-reminder-script-essential-perspectives-from-the-end-user/2026-06-29T17:03:07+00:00https://cenexel.com/the-placebo-control-reminder-script-in-depression-and-psychosis-trials-an-antidote-for-the-placebo-and-nocebo-response/2026-06-30T12:04:33+00:00https://cenexel.com/managing-the-placebo-and-nocebo-perils-applying-the-placebo-control-reminder-script-in-psychosis-trials/2026-06-30T12:05:04+00:00https://cenexel.com/broadening-the-empirical-exploration-of-the-placebo-control-reminder-script-to-reduce-placebo-and-nocebo-effects-a-preliminary-data-analysis-of-subjects-with-schizophrenia-and-schizoaffective-disorde/2026-06-30T12:09:49+00:00https://cenexel.com/preferences-of-the-opioid-use-disorder-patient-clinical-trial-methodologies-and-covid19-mitigations-that-motivate-participation/2026-06-30T12:04:00+00:00https://cenexel.com/a-subject-targeted-placebo-control-reminder-script-an-in-depth-empirical-exploration-of-how-subject-characteristics-moderate-placebo-response/2026-06-30T12:13:01+00:00https://cenexel.com/depression-treatment-gaithersburg/2026-06-30T12:14:41+00:00https://cenexel.com/cenexel-clinical-research-establishes-clinical-trial-centers-of-excellence-company/2026-06-29T14:18:58+00:00https://cenexel.com/enhancing-subjects-awareness-of-key-placebo-response-factors-the-importance-of-implementing-a-brief-educational-placebo-response-video/2026-06-30T12:23:05+00:00https://cenexel.com/taming-the-placebo-effect-in-depression-clinical-trials-the-methodological-implementation-of-a-placebo-control-reminder-script/2026-06-30T12:14:13+00:00https://cenexel.com/a-first-time-investigation-of-a-subject-intervention-to-reduce-the-placebo-and-nocebo-effects-a-multicenter-randomized-single-blind-all-placebo-study-of-a-placebo-control-reminde/2026-06-30T12:20:43+00:00https://cenexel.com/can-subjects-with-major-depression-learn-about-key-placebo-response-factors-the-effect-of-an-educational-placebo-response-video/2026-06-30T12:21:46+00:00https://cenexel.com/the-power-of-an-educational-placebo-response-video-strengthening-subject-placebo-response-awareness-across-demographic-variables-and-diagnoses/2026-06-30T12:22:27+00:00https://cenexel.com/enhancing-participant-retention-lessons-gained-from-attention-deficit-hyperactivity-and-anxiety-disorders-clinical-trial-methodologies/2026-06-29T17:05:04+00:00https://cenexel.com/key-factors-for-participant-retention-research-sites-study-data-and-strategies-for-preventing-attrition-in-depression-trials/2026-06-29T17:06:18+00:00https://cenexel.com/cultivating-retention-in-schizophrenia-and-schizoaffective-disorder-studies-patient-preferences-for-clinical-trial-methodologies-and-covid19-mitigations/2026-06-29T17:05:54+00:00https://cenexel.com/furthering-our-understanding-of-participant-retention-an-analysis-of-research-sites-study-data-and-methodological-correlates/2026-06-29T17:07:25+00:00https://cenexel.com/attending-to-the-patient-with-major-depression-preferences-for-clinical-trial-methodologies-and-covid19-mitigations/2026-06-29T17:10:31+00:00https://cenexel.com/giving-voice-to-patients-with-schizophrenia-or-schizoaffective-disorder-preferences-for-clinical-trial-methodologies-and-covid19-mitigations/2026-06-30T11:59:39+00:00https://cenexel.com/stuart-goldblatt-joins-cenexel-as-ceo/2026-06-29T11:16:45+00:00https://cenexel.com/cenexel-fcr-wins-tampa-bay-times-best-of-the-best-in-clinical-research-award/2026-06-29T11:16:23+00:00https://cenexel.com/placebo-and-nocebo-response-mitigation/2026-06-29T11:15:58+00:00https://cenexel.com/fda-approves-abrysvo-for-rsv/2026-06-29T11:15:06+00:00https://cenexel.com/electrophysiology-based-biomarkers-as-outcome-measures-demonstrate-signal-detection-and-reliability-in-a-simulated-clinical-trial-at-an-experienced-clinical-research-center-evaluating-study-drug-ke/2026-06-29T11:14:11+00:00https://cenexel.com/validation-of-a-suite-of-erp-and-qeeg-biomarkers-in-a-pre-competitive-industry-led-study-in-subjects-with-schizophrenia-and-healthy-volunteers-2/2026-06-29T11:13:22+00:00https://cenexel.com/global-raters-work-stress-and-task-burnout-an-empirical-exploration-of-our-primary-endpoint-evaluators/2026-06-29T11:13:01+00:00https://cenexel.com/revisiting-the-ketamine-model-for-schizophrenia-through-the-electrophysiology-looking-glass/2026-06-29T11:12:29+00:00https://cenexel.com/raterstressandburnout/2026-06-29T11:01:03+00:00https://cenexel.com/psychedelics-in-developmental-stuttering/2026-06-29T10:55:31+00:00https://cenexel.com/make-or-break-an-analgesic-non-opioid-clinical-trial/2026-06-29T11:10:49+00:00https://cenexel.com/antipsychotic-demonstrates-efficacy/2026-06-29T10:55:43+00:00https://cenexel.com/moving-forward-with-muscarinics/2026-06-29T10:58:02+00:00https://cenexel.com/effects-of-the-selective-ampa-modulator/2026-06-29T11:02:17+00:00https://cenexel.com/xanomeline-trospium-chloride-in-schizophrenia/2026-06-29T11:02:25+00:00https://cenexel.com/who-really-protects-patients-in-clinical-trials/2026-07-01T13:36:57+00:00https://cenexel.com/speaking-on-business-cenexel-utah/2026-07-01T13:38:15+00:00https://cenexel.com/the-las-vegas-public-affairs-show/2026-07-01T13:38:43+00:00https://cenexel.com/syneos-health-podcast-cns-summit-series/2026-07-01T13:39:07+00:00https://cenexel.com/breaking-new-ground-in-mental-health-with-dr-gerald-maguire/2026-07-01T14:13:48+00:00https://cenexel.com/behind-the-scenes-of-psychiatric-clinical-trials-with-dr-haig-goenjian/2026-07-01T14:14:31+00:00https://cenexel.com/overcoming-recruitment-and-retention-barriers-in-alzheimers-and-dementia-studies/2026-07-01T15:53:13+00:00https://cenexel.com/research-focused-on-you/2026-07-01T13:38:20+00:00https://cenexel.com/the-future-landscape-of-schizophrenia-research/2026-07-01T15:58:04+00:00https://cenexel.com/get-ready-for-a-new-wave-of-clinical-trials-in-schizophrenia/2026-07-01T13:44:07+00:00https://cenexel.com/abc-7-at-4-cutting-edge-research-reveals-ways-to-detect-alzheimers-earlier/2026-07-01T13:46:17+00:00https://cenexel.com/cns-trials-lessons-in-adherence-monitoring-from-a-phase-ii-study/2026-07-01T13:48:32+00:00https://cenexel.com/scope-summit-2025-opening-keynote-panel-what-do-real-patients-actually-talk-about/2026-07-01T13:51:40+00:00https://cenexel.com/norovirus-cases-are-rising-in-maryland/2026-07-01T14:04:33+00:00https://cenexel.com/how-skin-conditions-like-vitiligo-affect-mental-health/2026-07-01T14:14:25+00:00https://cenexel.com/mental-health-awareness-month/2026-07-01T14:12:17+00:00